During liver fibrosis, HSCs are a cellular source of IL-6 [51], which may might partly contribute to the elevation of α-SMA and type I and III collagens in HBV-positive sera and/or CsTP-treated LX-2 cells. Here, IL6 is linked to Hepatic fibrosis.